Updated from 6:53 a.m. EDT
Here are 10 things you should know for Monday, April 7:
1.-- U.S. stock futures were lower and European and Asian shares fell amid a selloff in technology stocks that started on Wall Street last week.
Japan's Nikkei 225 declined 1.7%.
2.-- The economic calendar in the U.S. on Monday includes Consumer Credit for February at 3 p.m. EDT.
3.-- U.S. stocks on Friday closed lower Friday and technology stocks tumbled as investors took profits after a week when the S&P 500 hit new records. The monthly U.S. jobs report showed signs that the labor market was beginning to shake off the effects of the winter chill.The Dow Jones Industrial Average fell 0.94% to close at 16,417.59, while the S&P 500 shed 1.25% to 1,865.09. The Nasdaq declined 2.6% to finish at 4,127.73.
4. -- India's Sun Pharmaceutical Industries agreed to buy generic drugmaker Ranbaxy Laboratories in a $4 billion deal, creating India's biggest pharmaceutical firm, with annual revenue estimated at $4.2 billion.
Ranbaxy is the leading drugmaker in India's $26 billion generic pharmaceutical industry, but it has faced penalties from U.S. regulators for years. The U.S. has banned imports of drugs from two of its factories because of concerns about quality control.
5. -- BlackRock (BLK) is reorganizing its senior management ranks as the world's largest money manager works toward an eventual succession plan for Larry Fink, its CEO and co-founder. BlackRock, which manages $4.3 trillion in assets, is shifting at least 10 senior executives into new or expanded roles, Reuters reported, citing an internal memo the news agency saw.
Fink and BlackRock President Rob Kapito will maintain their current roles.